Ranked #3,222 of 8,699 institutional investors
Sands Capital Alternatives, LLC
Arlington, VA
$608M
US stock portfolio at live prices · today −$4.6M (−0.76%)
Live prices, last trade 10:47 AM ET
- Value at quarter end (Q3 2026)
- $695M
- Change from Q2 2026
- +$81.1M (+13.23%)
- Positions
- 22 · 1 new, 1 sold out
- Filed
- Nov 13, 2026
Not counted in the ranking: none$93.8M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesALMR 18.9%KVYO 14.1%SGP 12.7%BBNX 8.91%TXG 4.21%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| ALMR Alamar Biosciences, Inc. | 4,230,926 | $115M | 18.9% | Unchanged |
| KVYO Klaviyo, Inc. | 3,827,359 | $85.4M | 14.1% | Reduced −3% |
| SGP SpyGlass Pharma, Inc. | 2,500,012 | $77.3M | 12.7% | Unchanged |
| BBNX Beta Bionics, Inc. | 3,997,898 | $54.2M | 8.91% | Added +8% |
| TXG 10x Genomics, Inc. | 481,770 | $25.6M | 4.21% | Unchanged |
| CPNG Coupang, Inc. | 1,244,409 | $18.2M | 2.99% | Reduced −6% |
| IKT Inhibikase Therapeutics, Inc. | 13,018,965 | $17.1M | 2.82% | Unchanged |
| DASH DoorDash, Inc. | 107,301 | $16.9M | 2.78% | Reduced −16% |
| IOT Samsara Inc. | 395,621 | $15.4M | 2.54% | Reduced −23% |
| ODTX Odyssey Therapeutics, Inc. | 875,000 | $15.1M | 2.49% | Unchanged |
| FRNM Freenome, Inc. | 1,201,998 | $11.3M | 1.86% | New |
| CBRS Cerebras Systems Inc. | 122,484 | $10.9M | 1.79% | Added +273% |
| DDOG Datadog, Inc. | 63,020 | $10.3M | 1.69% | Reduced −22% |
| TOST Toast, Inc. | 314,907 | $10.1M | 1.66% | Reduced −14% |
| TTAN ServiceTitan, Inc. | 91,101 | $7.2M | 1.18% | Reduced −16% |
| TARS Tarsus Pharmaceuticals, Inc. | 85,000 | $6.4M | 1.05% | Unchanged |
| SNOW Snowflake Inc. | 22,926 | $6.0M | 0.99% | Reduced −6% |
| BIOA BioAge Labs, Inc. | 786,353 | $3.5M | 0.58% | Unchanged |
| TSHA Taysha Gene Therapies, Inc. | 724,873 | $2.7M | 0.44% | Unchanged |
| ACRV Acrivon Therapeutics, Inc. | 2,289,271 | $2.6M | 0.43% | Unchanged |
| CADL Candel Therapeutics, Inc. | 405,837 | $2.1M | 0.34% | Unchanged |
| ABOS Acumen Pharmaceuticals, Inc. | 3,720,105 | $614K | 0.10% | Unchanged |
Sold out in Q3 2026
| Stock | Shares held at Q2 2026 | Worth today |
|---|---|---|
| FIG Figma, Inc. | 22,165 | $368K |